ENOV has 36-month beta value of 1.75. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 5 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ENOV is 55.15M, and currently, short sellers hold a 7.69% ratio of that float. The average trading volume of ENOV on October 04, 2024 was 635.88K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ENOV) stock’s latest price update
Enovis Corp (NYSE: ENOV)’s stock price has plunge by -2.15relation to previous closing price of 40.84. Nevertheless, the company has seen a -7.86% plunge in its stock price over the last five trading sessions. benzinga.com reported 2024-10-03 that JMP Securities initiated coverage on Enovis Corporation ENOV, a medical technology company focusing on orthopedics.
ENOV’s Market Performance
ENOV’s stock has fallen by -7.86% in the past week, with a monthly drop of -9.65% and a quarterly drop of -10.88%. The volatility ratio for the week is 2.90% while the volatility levels for the last 30 days are 2.85% for Enovis Corp The simple moving average for the past 20 days is -7.26% for ENOV’s stock, with a -23.24% simple moving average for the past 200 days.
Analysts’ Opinion of ENOV
JP Morgan, on the other hand, stated in their research note that they expect to see ENOV reach a price target of $53. The rating they have provided for ENOV stocks is “Neutral” according to the report published on June 13th, 2024.
Stephens gave a rating of “Overweight” to ENOV, setting the target price at $72 in the report published on February 13th of the current year.
ENOV Trading at -9.51% from the 50-Day Moving Average
After a stumble in the market that brought ENOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.55% of loss for the given period.
Volatility was left at 2.85%, however, over the last 30 days, the volatility rate increased by 2.90%, as shares sank -7.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.96% lower at present.
During the last 5 trading sessions, ENOV fell by -7.86%, which changed the moving average for the period of 200-days by -25.48% in comparison to the 20-day moving average, which settled at $42.93. In addition, Enovis Corp saw -28.67% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ENOV
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.55 for the gross margin
The net margin for Enovis Corp stands at -0.05. The total capital return value is set at -0.02. Equity return is now at value -3.18, with -2.17 for asset returns.
Based on Enovis Corp (ENOV), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 0.05. The debt to equity ratio resting at 0.42. The interest coverage ratio of the stock is -1.66.
Currently, EBITDA for the company is 194.39 million with net debt to EBITDA at 10.1. When we switch over and look at the enterprise to sales, we see a ratio of 1.89. The receivables turnover for the company is 4.85for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.26.
Conclusion
To put it simply, Enovis Corp (ENOV) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
